CCNA2 and prostate cancer: Indeed, knockdown expression of cyclin A2 using siRNA or inhibition of cyclin A2 activity using small molecule were shown to inhibit cell growth, invasion, and migration in several lines of prostate cancer cells [49, 51, 52].